Abstract
The current study aimed to examine the impact of COVID-19 pandemic on patient-related delay with ST-segment elevation myocardial infarction (STEMI) at a tertiary center in the United Kingdom. The study demonstrated a significant delay in symptom-to-first medical contact and a higher cardiac troponin-I level on admission in patients with STEMI during the COVID-19 pandemic versus the pre-COVID era.
Original language | English |
---|---|
Pages (from-to) | 45-48 |
Number of pages | 4 |
Journal | American Heart Journal |
Volume | 226 |
Early online date | 11 May 2020 |
DOIs | |
Publication status | Published - Aug 2020 |